ENTITY
Sansure Biotech

Sansure Biotech (688289 CH)

47
Analysis
Health Care • China
Sansure Biotech Inc. operates as an in vitro diagnostic solution provider. The Company develops and sells upstream nucleic acid extraction kits, novel coronavirus nucleic acid detection kits, and other products. Sansure Biotech markets its products worldwide.
more
bullish•Ninebot
•21 Apr 2021 09:59

STAR Board - STAR50 Index Rebalance June Preview: Falling Volumes Increasing Impact

We see 5 changes to the STAR50 Index at the June review. The deletions are high probability, but there is uncertainty on the inclusions due to a...

Logo
727 Views
Share
bullish•Ninebot
•09 Mar 2021 05:36

STAR50 Index Rebalance June Preview: Selloff Presents Opportunity

While the deletions at the STAR50 June review can be picked fairly easily, index rules that are not specific give rise to two sets of potential...

Logo
595 Views
Share
x